ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.08M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−240.00
Price / share
$530.48
Trade value
$127.31K
% of position
Common Stock
Shares
−1.02K
Price / share
$531.54
Trade value
$544.30K
% of position
Common Stock
Shares
−2.38K
Price / share
$532.46
Trade value
$1.27M
% of position
Common Stock
Shares
−1.82K
Price / share
$533.32
Trade value
$969.58K
% of position
Common Stock
Shares
−640.00
Price / share
$534.41
Trade value
$342.02K
% of position
Common Stock
Shares
−535.00
Price / share
$535.67
Trade value
$286.58K
% of position
Common Stock
Shares
−865.00
Price / share
$536.66
Trade value
$464.21K
% of position
Common Stock
Shares
−760.00
Price / share
$537.74
Trade value
$408.68K
% of position
Common Stock
Shares
−401.00
Price / share
$538.55
Trade value
$215.96K
% of position
Common Stock
Shares
−239.00
Price / share
$539.60
Trade value
$128.96K
% of position
Common Stock
Shares
−169.00
Price / share
$541.62
Trade value
$91.53K
% of position
Common Stock
Shares
−391.00
Price / share
$542.67
Trade value
$212.19K
% of position
Common Stock
Shares
−40.00
Price / share
$543.85
Trade value
$21.75K
% of position
Net shares
+0.00
Net value
-$3.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/16/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −240.00 | $530.48 | $127.31K | 0.1% | 333.94K | 333.70K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −1.02K | $531.54 | $544.30K | 0.3% | 333.70K | 332.68K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −2.38K | $532.46 | $1.27M | 0.7% | 332.68K | 330.30K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −1.82K | $533.32 | $969.58K | 0.6% | 330.30K | 328.48K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −640.00 | $534.41 | $342.02K | 0.2% | 328.48K | 327.84K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −535.00 | $535.67 | $286.58K | 0.2% | 327.84K | 327.31K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −865.00 | $536.66 | $464.21K | 0.3% | 327.31K | 326.44K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −760.00 | $537.74 | $408.68K | 0.2% | 326.44K | 325.68K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −401.00 | $538.55 | $215.96K | 0.1% | 325.68K | 325.28K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −239.00 | $539.60 | $128.96K | 0.1% | 325.28K | 325.04K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −169.00 | $541.62 | $91.53K | 0.1% | 325.04K | 324.87K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −391.00 | $542.67 | $212.19K | 0.1% | 324.87K | 324.48K |
| Common Stock Indirect | 10/16/2026 | S · Sale | −40.00 | $543.85 | $21.75K | 0.0% | 324.48K | 324.44K |
| Total | +0.00 | -$3.96M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
214.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/16/2026 | M · Option Exercise | −9.50K | 117.76 | — | 214.41K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.90K | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 249.11K | Indirect |
| Common Stock | 166.00 | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |